Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis

Journal of Autoimmunity

Volumn 35, Issue 3, 2010, Pages 176-180

  Bernuzzi, Francesca ^a,b   Fenoglio, Daniela ^c   Battaglia, Florinda ^c   Fravega, Marco ^c   Gershwin, M Eric ^d   Indiveri, Francesco ^c   Ansari, Aftab A ^e   Podda, Mauro ^a,b   Invernizzi, Pietro ^a,d   Filaci, Gilberto ^c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune cholangitis CD8 T regulatory cells; CD39; IL7 R

Indexed keywords

CD39 ANTIGEN; INTERLEUKIN 7 RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, CD; APYRASE; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL MOVEMENT; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LIVER; LIVER CIRRHOSIS, BILIARY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 77957820979     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.06.004     Document Type: Article

References (58)

1. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
2. Lleo A., Invernizzi P., Mackay I.R., Prince H., Zhong R.Q., Gershwin M.E. Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol 2008, 14:3328-3337.
3. Gershwin M.E., Mackay I.R. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008, 47:737-745.
4. Invernizzi P., Lleo A., Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis 2007, 27:161-172.
5. Van de Water J., Ansari A., Prindiville T., Coppel R.L., Ricalton N., Kotzin B.L., et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995, 181:723-733.
6. Shimoda S., Nakamura M., Ishibashi H., Hayashida K., Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995, 181:1835-1845.
7. Shimoda S., Nakamura M., Ishibashi H., Kawano A., Kamihira T., Sakamoto N., et al. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology 2003, 124:1915-1925.
8. Chuang Y.H., Lian Z.X., Tsuneyama K., Chiang B.L., Ansari A.A., Coppel R.L., et al. Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 2006, 26:232-240.
9. Lan R.Y., Salunga T.L., Tsuneyama K., Lian Z.X., Yang G.X., Hsu W., et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 2009, 32:43-51.
10. Brusko T.M., Putnam A.L., Bluestone J.A. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 2008, 223:371-390.
11. Jordan M.A., Baxter A.G. The genetics of immunoregulatory T cells. J Autoimmun 2008, 31:237-244.
12. Abraham M., Karni A., Dembinsky A., Miller A., Gandhi R., Anderson D., et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 2008, 30:21-28.
13. Aoki C.A., Roifman C.M., Lian Z.X., Bowlus C.L., Norman G.L., Shoenfeld Y., et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 2006, 27:50-53.
14. Wakabayashi K., Lian Z.X., Moritoki Y., Lan R.Y., Tsuneyama K., Chuang Y.H., et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 2006, 44:1240-1249.
15. Zhang W., Sharma R., Ju S.T., He X.S., Tao Y., Tsuneyama K., et al. Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology 2009, 49:545-552.
16. Oertelt S., Lian Z.X., Cheng C.M., Chuang Y.H., Padgett K.A., He X.S., et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006, 177:1655-1660.
17. Yang G.X., Lian Z.X., Chuang Y.H., Moritoki Y., Lan R.Y., Wakabayashi K., et al. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 2008, 47:1974-1982.
18. Lan R.Y., Cheng C., Lian Z.X., Tsuneyama K., Yang G.X., Moritoki Y., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006, 43:729-737.
19. Sasaki M., Ikeda H., Sawada S., Sato Y., Nakanuma Y. Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis. J Clin Pathol 2007, 60:1102-1107.
20. Sakaki M., Hiroishi K., Baba T., Ito T., Hirayama Y., Saito K., et al. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol Res 2008, 38:354-361.
21. Ludwig J., Dickson E.R., McDonald G.S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978, 379:103-112.
22. Riley J.L., Mao M., Kobayashi S., Biery M., Burchard J., Cavet G., et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci U S A 2002, 99:11790-11795.
23. Piccirillo C.A. Regulatory T cells in health and disease. Cytokines 2008, 43:395-401.
24. Filaci G., Suciu-Foca N. CD8+ T suppressor cells are back to the game: are they players in autoimmunity?. Autoimmun Rev 2002, 1:279-283.
25. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
26. Fousteri G., Dave A., Juntti T., von Herrath M. CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virally-induced autoimmune diabetes. J Autoimmun 2009, 32:70-77.
27. Venkatesh J., Kawabata D., Kim S., Xu X., Chinnasamy P., Paul E., et al. Selective regulation of autoreactive B cells by FcgammaRIIB. J Autoimmun 2009, 32:149-157.
28. Crispin J.C., Tsokos G.C. Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun Rev 2009, 8:190-195.
29. Rajaiah R., Moudgil K.D. Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun Rev 2009, 8:388-393.
30. Hondowicz B.D., Fields M.L., Nish S.A., Larkin J., Caton A.J., Erikson J. Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity. J Autoimmun 2008, 31:98-109.
31. Mackay I.R., Leskovsek N.V., Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 2008, 30:5-11.
32. Lleo A., Selmi C., Invernizzi P., Podda M., Gershwin M.E. The consequences of apoptosis in autoimmunity. J Autoimmun 2008, 31:257-262.
33. Cao D., van Vollenhoven R., Klareskog L., Trollmo C., Malmstrom V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004, 6:R335-R346.
34. van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., Taams L.S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004, 50:2775-2785.
35. Filaci G., Bacilieri S., Fravega M., Monetti M., Contini P., Ghio M., et al. Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus. J Immunol 2001, 166:6452-6457.
36. Lyssuk E.Y., Torgashina A.V., Soloviev S.K., Nassonov E.L., Bykovskaia S.N. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 2007, 601:113-119.
37. Liu M.F., Wang C.R., Fung L.L., Wu C.R. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004, 59:198-202.
38. Eisenberg R. Why can't we find a new treatment for SLE?. J Autoimmun 2009, 32:223-230.
39. Fernandez D., Perl A. Metabolic control of T cell activation and death in SLE. Autoimmun Rev 2009, 8:184-189.
40. Kong Y.C., Morris G.P., Brown N.K., Yan Y., Flynn J.C., David C.S. Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J Autoimmun 2009, 33:239-246.
41. Morris G.P., Brown N.K., Kong Y.C. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun 2009, 33:68-76.
42. Jacobson E.M., Huber A., Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008, 30:58-62.
43. Mikulkova Z., Praksova P., Stourac P., Bednarik J., Strajtova L., Pacasova R., et al. Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis. Cell Immunol 2010, 262:75-79.
44. Gebe J.A., Unrath K.A., Yue B.B., Miyake T., Falk B.A., Nepom G.T. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice. J Autoimmun 2008, 30:197-206.
45. Moraes-Fontes M.F., Rebelo M., Caramalho I., Zelenay S., Bergman M.L., Coutinho A., et al. Steroid treatments in mice do not alter the number and function of regulatory T cells, but amplify cyclophosphamide-induced autoimmune disease. J Autoimmun 2009, 33:109-120.
46. Hsu W., Zhang W., Tsuneyama K., Moritoki Y., Ridgway W.M., Ansari A.A., et al. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice. Hepatology 2009, 49:133-140.
47. Filaci G., Fravega M., Negrini S., Procopio F., Fenoglio D., Rizzi M., et al. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol 2004, 65:142-156.
48. Weng N.P., Akbar A.N., Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 2009, 30:306-312.
49. Konya C., Goronzy J.J., Weyand C.M. Treating autoimmune disease by targeting CD8(+) T suppressor cells. Expert Opin Biol Ther 2009, 9:951-965.
50. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006, 203:1701-1711.
51. McKay F.C., Swain L.I., Schibeci S.D., Rubio J.P., Kilpatrick T.J., Heard R.N., et al. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis. J Autoimmun 2008, 31:52-58.
52. Mizumoto N., Kumamoto T., Robson S.C., Sevigny J., Matsue H., Enjyoji K., et al. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 2002, 8:358-365.
53. Borsellino G., Kleinewietfeld M., Di Mitri D., Sternjak A., Diamantini A., Giometto R., et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007, 110:1225-1232.
54. Filaci G., Rizzi M., Setti M., Fenoglio D., Fravega M., Basso M., et al. Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann N Y Acad Sci 2005, 1050:115-123.
55. Ansari A.A., Gershwin M.E. Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose. J Autoimmun 2005, 33:165-169.
56. Whittingham S., Rowley M.J., Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 2008, 31:197-200.
57. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 2008, 30:105-107.
58. Gershwin M.E. The mosaic of autoimmunity. Autoimmun Rev 2008, 7:161-163.